Mar 13, 2024
Prescription Drug Data Collection (RxDC) reporting for reference year 2023 is required to be submitted no later than 6/1/2024. This submission must include certain data elements that were not required for the initial submission.
As always, Aetna is committed to complying with all legal and regulatory requirements affecting business operations and their customer's health benefits. Therefore, Aetna has developed a process to support their plan sponsors in the submission of these reports.
Aetna will request information from plan sponsors
Starting Friday, March 15th, Aetna will begin emailing plan sponsors to collect information for this years report. In 2024, Aetna will require the following data from all plan sponsors included in Aetna’s D1 file:
- Total premium paid by members for the reference year
- Total premium paid by employer for the reference year
- Funding Arrangement
- Issuer Name/Legal Entity
If a self-insured plan sponsor requests to be excluded from Aetna’s D1 file, employers do not need to complete this data collection process. Instead, plan sponsors should contact their account representative to request an exception.
To learn more about the reporting requirements, refer to the RxDC Reporting Instructions.
What plan sponsors need to do
Complete the fields provided in the emailed form no later than 4/12/2024.
If any plan sponsor does not provide the requested data by April 12, Aetna will submit the report without the required plan sponsor data. Failure to respond with complete and correct information will impact Aetna's ability to accurately report on the plan sponsor’s behalf, and Aetna will not be responsible for any liability associated with the inaccurate report. It may be necessary for the employer to submit this information to CMS directly.
Please reach out to your Amwins Connect Sales Representative with any questions.
